ERCC2 and urinary system neoplasm: Our EA analysis coupled with a detailed mutational map enables the prediction that selection pressure is operative for at least some DNA repair genes, such as ERCC2, in patients with a medium mutational burden, particularly those affected by tumors of the urinary tract.